Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1128/AAC.03832-14 http://scihub22266oqcxt.onion/10.1128/AAC.03832-14 C4249526!4249526!25288090     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25288090&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Antimicrob+Agents+Chemother 2014 ; 58 (12): 7583-5 Nephropedia Template TP {{tp|p=25288090|t=2014. Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis |pdf=|usr=}}{{25288090}} gab.com Text Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis JO: Antimicrob Agents Chemother http://www.kidney.de/pget.php?&tw=1&pmid=25288090 #FOAvip This article reports anti-Toxoplasma gondii activity of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione. The compound displayed significant and reproducible antiparasitic effects at nontoxic concentrations for the host cells, with an experimentally determined 50% inhibitory concentration (IC50) at least 30 times better than that of the known chemotherapeutic agent sulfadiazine. Purine nucleoside phosphorylase was defined as the probable target for anti-Toxoplasma activity of the tested compound. These results provide the foundation for future work to develop a new class of medicines to better treat toxoplasmosis. Twit Text FOAVip Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis ????Antimicrob Agents Chemother http://www.kidney.de/pget.php?&tw=1&pmid=25288090 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25288090 #FOAvip English Wikipedia <ref>{{Cite pmid|25288090}}</ref> Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis #MMPMID25288090 Dzitko K; Paneth A; Plech T; Pawe?czyk J; W?gli?ska L; Paneth P Antimicrob Agents Chemother 2014[Dec]; 58 (12): 7583-5 PMID25288090show ga This article reports anti-Toxoplasma gondii activity of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione. The compound displayed significant and reproducible antiparasitic effects at nontoxic concentrations for the host cells, with an experimentally determined 50% inhibitory concentration (IC50) at least 30 times better than that of the known chemotherapeutic agent sulfadiazine. Purine nucleoside phosphorylase was defined as the probable target for anti-Toxoplasma activity of the tested compound. These results provide the foundation for future work to develop a new class of medicines to better treat toxoplasmosis. äTriazole-Based Compound as a Candidate To Develop Novel Medicines To T(epmc).pdf DeepDyve Pubget Overpricing